Cardiac Screening

The hd Group Medical is involved itself With Bpl A Limited To Put on the market His Cardiac Sorting Device in India

The Medical HD entered into a distribution agreement with BPL A Limited for the distribution of the first one produces pipe line of the business, ViScope 100. The distribution agreement is estimated to USES$10 millions of (Rs. 45 Crores).

Unveil this to the media persons here today, Mr. Jay Jethwa, the General Director and CEO of HD Groupsaid Medical, "ViScope is a Sorting, Cardiac device and Visual Audio that returns able the doctors to Visulaize the sounds of heart with to hear the better one. ViScope also renders capable the better detection of murmurs and of other heart components solid if as to attain one sort very effective cardiac abnormalities"

Comment on on the agreement, Mr. A. Vijay Simha, the Director of exploitation and vice President of BPL Limited said, "The ViScope 100 representatives the new paradigm in the health diagnosis for the masses, giving to be able of the to the doctors to diagnose with a bigger degree of precision and of effectiveness. This is a true example of how the advanced technology potentially can do to lower the to prevail the high costs of medical services of services of health and reasonable brand to the million".

M Jethwa added that the HD Group Medical is a global business with the offices in India, WORE and Australia. Most of his research development for the technology is executed in Chennai. The business was been founded in 2005 to market his of property and patented the heart technology solid. The business has 14 patents in expectation and a patent that already was granted in the field of cardiac examination.

M Jethwa added more than the business is in the process of sign the similar agreements of distribution in the somewhere else world. Mr. Damon Coffman, the technology Officer, Principal and global of the business, said that the business would introduce diagnostic products more of the in advance in Europe, United States and Japan in the future close.

"The business decided to undertake all his research development to India as the reserve of human talent is very good here for any sound R&D conditions. The business has the strategic collaboration with a lot of to take the global institutions for the essays clinics and technology validation", said Mr. Arvind Thiagarajan, the principal inventor.

M B Ramakrishnan, CEO, the business Clinic, Chennai and the financial counselor of HD Group Medical said that the business student already surpassing USES$ 8 million towards the development of the product.

The HD Group Medical is a global business with the offices in India, WORE and Australia. Most of his research development for the technology is executed in Chennai. The business was been founded in 2005 to market his of property and patented the heart technology solid. The business has 14 patents in expectation and a patent that already was granted in the field of cardiac examination.